{"AllianceGenome": "33267", "HGNC": "33267", "MIM": "300648", "_id": "541466", "_version": 1, "accession": {"genomic": ["AC240442.3", "BX537333.1", "CP068255.2", "NC_000023.11", "NC_060947.1"], "protein": ["AAI40914.1", "AAW66464.1", "NP_001017417.1", "Q5HYN5.1", "XP_005278198.1", "XP_011529654.1", "XP_047298129.1", "XP_054183195.1", "XP_054183196.1"], "rna": ["AA757285.1", "AY743709.1", "BC140913.1", "NM_001017417.3", "XM_005278141.5", "XM_011531352.2", "XM_047442173.1", "XM_054327220.1", "XM_054327221.1"], "translation": [{"protein": "XP_054183195.1", "rna": "XM_054327220.1"}, {"protein": "AAI40914.1", "rna": "BC140913.1"}, {"protein": "XP_011529654.1", "rna": "XM_011531352.2"}, {"protein": "AAW66464.1", "rna": "AY743709.1"}, {"protein": "XP_054183196.1", "rna": "XM_054327221.1"}, {"protein": "NP_001017417.1", "rna": "NM_001017417.3"}, {"protein": "XP_005278198.1", "rna": "XM_005278141.5"}, {"protein": "XP_047298129.1", "rna": "XM_047442173.1"}]}, "alias": ["CT45", "CT45-1", "CT45.1"], "ensembl": {"gene": "ENSG00000268940", "protein": ["ENSP00000470185", "ENSP00000472303"], "transcript": ["ENST00000594117", "ENST00000594565"], "translation": [{"protein": "ENSP00000472303", "rna": "ENST00000594565"}, {"protein": "ENSP00000470185", "rna": "ENST00000594117"}], "type_of_gene": "protein_coding"}, "entrezgene": "541466", "exons": [{"cdsend": 135723033, "cdsstart": 135718940, "chr": "X", "position": [[135713452, 135713690], [135718934, 135719109], [135721027, 135721276], [135721657, 135721751], [135722975, 135723246]], "strand": 1, "transcript": "NM_001017417", "txend": 135723246, "txstart": 135713452}], "exons_hg19": [{"cdsend": 134891326, "cdsstart": 134852701, "chr": "X", "position": [[134847184, 134847423], [134852695, 134852870], [134889320, 134889569], [134889950, 134890044], [134891268, 134891539]], "strand": 1, "transcript": "NM_001017417", "txend": 134891539, "txstart": 134847184}], "generif": [{"pubmed": 19296537, "text": "Over-expression of CT45 is associated with cancer."}, {"pubmed": 20133697, "text": "Hodgkin lymphoma has the highest CT45 expression among all malignancies tested, in diffuse large B-cell lymphomas it is similar to that seen in epithelial cancers, and not present in low-grade non-Hodgkin B-cell lymphomas."}, {"pubmed": 24901056, "text": "CT45A1 functions as a novel proto-oncogene to trigger oncogenesis and metastasis."}, {"pubmed": 26098711, "text": "These data verify CT45 expression and promoter hypomethylation as possible prognostic biomarkers, and suggest CT45 as an immunological or therapeutic target in Epithelial ovarian cancer"}, {"pubmed": 28901509, "text": "Following CT45A1 silencing, the expressions of Bcl2, survivin, MMP2, MMP9, pERK1/2 and pCREB were downregulated and the expression of Bax was upregulated."}, {"pubmed": 33602962, "text": "YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer."}, {"pubmed": 34172717, "text": "CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through beta-catenin."}, {"pubmed": 34503444, "text": "Uev1A promotes breast cancer cell migration by up-regulating CT45A expression via the AKT pathway."}, {"pubmed": 37924456, "text": "Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways."}], "genomic_pos": {"chr": "X", "end": 135723539, "ensemblgene": "ENSG00000268940", "start": 135713639, "strand": 1}, "genomic_pos_hg19": [{"chr": "HG1443_HG1444_PATCH", "end": 134857255, "start": 134847482, "strand": 1}, {"chr": "HG1443_HG1444_PATCH", "end": 134971309, "start": 134893822, "strand": -1}, {"chr": "X", "end": 134857354, "start": 134847185, "strand": 1}, {"chr": "X", "end": 134891885, "start": 134883488, "strand": 1}], "go": {"MF": {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}}, "homologene": {"genes": [[9598, 465877], [9606, 441519], [9606, 541465], [9606, 541466], [9606, 728911], [9606, 101060211], [9606, 102723680], [9606, 102723737]], "id": 45134}, "interpro": {"desc": "INTS6/SAGE1/DDX26B/CT45, C-terminal", "id": "IPR029307", "short_desc": "INT_SG_DDX_CT_C"}, "ipi": "IPI00869227", "map_location": "Xq26.3", "name": "cancer/testis antigen family 45 member A1", "other_names": ["cancer/testis antigen 45-1", "cancer/testis antigen 45A1", "cancer/testis antigen CT45-1", "cancer/testis antigen family 45 member A1"], "pfam": "PF15300", "pharmgkb": "PA164718185", "pharos": {"target_id": 18605, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": {"id": "GNF227619", "relationship": "is"}}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1"], "protein": ["NP_001017417.1", "XP_005278198.1", "XP_011529654.1", "XP_047298129.1", "XP_054183195.1", "XP_054183196.1"], "rna": ["NM_001017417.3", "XM_005278141.5", "XM_011531352.2", "XM_047442173.1", "XM_054327220.1", "XM_054327221.1"], "translation": [{"protein": "XP_054183195.1", "rna": "XM_054327220.1"}, {"protein": "XP_011529654.1", "rna": "XM_011531352.2"}, {"protein": "XP_054183196.1", "rna": "XM_054327221.1"}, {"protein": "NP_001017417.1", "rna": "NM_001017417.3"}, {"protein": "XP_005278198.1", "rna": "XM_005278141.5"}, {"protein": "XP_047298129.1", "rna": "XM_047442173.1"}]}, "reporter": {"HG-U133_Plus_2": ["1567912_s_at", "235700_at"], "HTA-2_0": ["TC0X000653.hg.1", "TC0X002340.hg.1"], "HuEx-1_0": ["3992236", "3992270", "4023228", "4023242", "4023254"], "HuGene-1_1": ["8170052", "8170060", "8170068", "8175336", "8175344", "8175353"], "HuGene-2_1": ["17107159", "17107167", "17107175", "17114453", "17114461"]}, "retired": 257122, "summary": "Predicted to be involved in snRNA 3'-end processing. Predicted to be part of integrator complex. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "CT45A1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1970854"}, "unigene": ["Hs.535080", "Hs.460937"], "uniprot": {"Swiss-Prot": "Q5HYN5"}}